133 related articles for article (PubMed ID: 33277106)
1. Can chloroquine/hydroxychloroquine prove efficient in cancer cachexia? A hypothesis in the era of COVID-19.
Kiedrowski M; Kapala P; Kiedrowska M; Skoczynska A; Czerw A; Deptała A
Med Hypotheses; 2021 Jan; 146():110434. PubMed ID: 33277106
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.
Richard SA; Kampo S; Hechavarria ME; Sackey M; Buunaaim ADB; Kuugbee ED; Anabah TW
J Immunol Res; 2020; 2020():4582612. PubMed ID: 33062720
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
4. Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine.
Bonam SR; Muller S; Bayry J; Klionsky DJ
Autophagy; 2020 Dec; 16(12):2260-2266. PubMed ID: 32522067
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
Shah S; Das S; Jain A; Misra DP; Negi VS
Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
[TBL] [Abstract][Full Text] [Related]
7. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
Fatima U; Rizvi SSA; Fatima S; Hassan MI
J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
[TBL] [Abstract][Full Text] [Related]
8. Chloroquine and COVID-19-A systems biology model uncovers the drug's detrimental effect on autophagy and explains its failure.
Kapuy O; Korcsmáros T
PLoS One; 2022; 17(4):e0266337. PubMed ID: 35390060
[TBL] [Abstract][Full Text] [Related]
9. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
Rodrigo C; Fernando SD; Rajapakse S
Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
[TBL] [Abstract][Full Text] [Related]
10. What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.
Altulea D; Maassen S; Baranov MV; van den Bogaart G
J Mol Cell Biol; 2021 Jul; 13(3):175-184. PubMed ID: 33693723
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
[TBL] [Abstract][Full Text] [Related]
12. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
Derwand R; Scholz M
Med Hypotheses; 2020 Sep; 142():109815. PubMed ID: 32408070
[TBL] [Abstract][Full Text] [Related]
13. The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases.
Martinez GP; Zabaleta ME; Di Giulio C; Charris JE; Mijares MR
Curr Pharm Des; 2020; 26(35):4467-4485. PubMed ID: 32634079
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.
Chen Y; Li MX; Lu GD; Shen HM; Zhou J
Int J Biol Sci; 2021; 17(6):1538-1546. PubMed ID: 33907517
[TBL] [Abstract][Full Text] [Related]
15. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
[TBL] [Abstract][Full Text] [Related]
16. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
Meo SA; Klonoff DC; Akram J
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4539-4547. PubMed ID: 32373993
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine and its derivatives in the management of COVID-19: A scoping review.
Pimentel J; Andersson N
Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192
[TBL] [Abstract][Full Text] [Related]
19. COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.
Zhou D; Dai SM; Tong Q
J Antimicrob Chemother; 2020 Jul; 75(7):1667-1670. PubMed ID: 32196083
[TBL] [Abstract][Full Text] [Related]
20. Possible mechanistic insights into iron homeostasis role of the action of 4-aminoquinolines (chloroquine/hydroxychloroquine) on COVID-19 (SARS-CoV-2) infection.
Batiha GE; Shaheen HM; Al-Kuraishy HM; Teibo JO; Akinfe OA; Al-Garbee AI; Teibo TKA; Kabrah SM
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7565-7584. PubMed ID: 34919258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]